for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Henan Taloph Pharmaceutical Stock Co.,

600222.SS

Latest Trade

4.66CNY

Change

-0.03(-0.64%)

Volume

1,358,247

Today's Range

4.65

 - 

4.72

52 Week Range

3.25

 - 

7.39

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4.69
Open
4.69
Volume
1,358,247
3M AVG Volume
154.20
Today's High
4.72
Today's Low
4.65
52 Week High
7.39
52 Week Low
3.25
Shares Out (MIL)
550.30
Market Cap (MIL)
2,691.53
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2019 Henan Taloph Pharmaceutical Stock Co Ltd Earnings Release

Latest Developments

More

Henan Taloph Pharmaceutical Elects Li Jingliang As Chairman

Henan Taloph Pharmaceutical Revises Share Buyback Plan To 125-250 Million Yuan

Henan Taloph Pharmaceutical To Boost Unit's Capital Via Debt-To-Equity Swap

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Henan Taloph Pharmaceutical Stock Co.,

HENANTALOPHPHARMACEUTICALSTOCKCO., LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The Company's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The Company distributes its products mainly within domestic market.

Industry

Major Drugs

Contact Info

No. 8

Jinsuo Road

Hi-Tech Industrial Development Zone

+86.371.67992262

http://www.taloph.com

Executive Leadership

Jingliang Li

Chairman of the Board

Hailin Zhao

Finance Director, Deputy General Manager

Hui Li

General Manager, Director

Jianchao Luo

Secretary of the Board, Deputy General Manager

Jiwu Zhang

Deputy General Manager, Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
2.23
Price To Book (MRQ)
1.97
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
86.50
LT Debt To Equity (MRQ)
34.36
Return on Investment (TTM)
-4.81
Return on Equity (TTM)
-3.43

Latest News

Latest News

BRIEF-Henan Taloph Pharmaceutical Stock passes review of high-tech enterprise recognition

* Says it passes the review of high-tech enterprise recognition and could enjoy a tax preference of 15 percent for three years

BRIEF-Henan Taloph Pharmaceutical Stock unit receives GMP certificate

* Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Zhejiang Food and Drug Administration

BRIEF-Henan Taloph Pharmaceutical Stock says change of accounting policy

* Says it changes accounting policy regarding government subsidy

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up